{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:21:01Z","timestamp":1794482461307,"version":"4.9.1"},"reference-count":75,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"47","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/md.0000000000005268","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T07:56:28Z","timestamp":1479974188000},"page":"e5268","source":"Crossref","is-referenced-by-count":27,"title":["Genetic aspects of pituitary carcinoma"],"prefix":"10.1097","volume":"95","author":[{"given":"Zijiang","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210309","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/foc.2004.16.4.8","article-title":"Pituitary carcinoma: a review of the literature","volume":"16","author":"Ragel","year":"2004","journal-title":"Neurosurg Focus"},{"key":"R2-14-20210309","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<804::AID-CNCR18>3.0.CO;2-3","article-title":"Pituitary carcinoma: a clinicopathologic study of 15 cases","volume":"79","author":"Pernicone","year":"1997","journal-title":"Cancer"},{"key":"R3-14-20210309","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1530\/eje.1.02339","article-title":"What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics","volume":"156","author":"Gurlek","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"R4-14-20210309","first-page":"842","article-title":"H-ras mutations in human pituitary carcinoma metastases","volume":"78","author":"Pei","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-14-20210309","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10143-014-0525-y","article-title":"Invasive adenoma and pituitary carcinoma: a SEER database analysis","volume":"37","author":"Hansen","year":"2014","journal-title":"Neurosurg Rev"},{"key":"R6-14-20210309","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s11102-013-0537-6","article-title":"Pituitary carcinoma with fourth ventricle metastasis: treatment by excision and Gamma-knife radiosurgery","volume":"17","author":"Park","year":"2014","journal-title":"Pituitary"},{"key":"R7-14-20210309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/RLU.0000000000000589","article-title":"The use of (68)Ga DOTATATE PET\/CT for diagnostic assessment and monitoring of (177)Lu DOTATATE therapy in pituitary carcinoma","volume":"40","author":"Novruzov","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R8-14-20210309","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jocn.2014.12.007","article-title":"The role of temozolomide in the treatment of aggressive pituitary tumors","volume":"22","author":"Liu","year":"2015","journal-title":"J Clin Neurosci"},{"key":"R9-14-20210309","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1210\/jc.2012-2924","article-title":"DNA mismatch repair protein (MSH6) correlated with the responses of atypical pituitary adenomas and pituitary carcinomas to temozolomide: the national cooperative study by the Japan Society for Hypothalamic and Pituitary Tumors","volume":"98","author":"Hirohata","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R10-14-20210309","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1210\/jc.2011-2031","article-title":"Clinical review: pituitary carcinoma: difficult diagnosis and treatment","volume":"96","author":"Heaney","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-14-20210309","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s11102-011-0346-8","article-title":"Anti-VEGF therapy in pituitary carcinoma","volume":"15","author":"Ortiz","year":"2012","journal-title":"Pituitary"},{"key":"R12-14-20210309","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11060-011-0532-6","article-title":"MGMT promoter methylation and immunoexpression in aggressive pituitary adenomas and carcinomas","volume":"104","author":"Salehi","year":"2011","journal-title":"J Neurooncol"},{"key":"R13-14-20210309","first-page":"509","article-title":"Transforming growth factor-beta, transforming growth factor-beta receptor II, and p27Kip1 expression in nontumorous and neoplastic human pituitaries","volume":"151","author":"Jin","year":"1997","journal-title":"Am J Pathol"},{"key":"R14-14-20210309","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajpath.2013.03.001","article-title":"New roles of cyclin D1","volume":"183","author":"Pestell","year":"2013","journal-title":"Am J Pathol"},{"key":"R15-14-20210309","first-page":"589","article-title":"Cyclin D1 immunoexpression in adenohypophysial tumors","volume":"68","author":"Scheithauer","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"R16-14-20210309","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/eje.0.143r001","article-title":"Cyclin D and cyclin E expression in normal and adenomatous pituitary","volume":"143","author":"Jordan","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"R17-14-20210309","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jnci.2011.11.003","article-title":"Differential expression of cyclin D1 in human pituitary tumors: relation to MIB-1 and p27\/Kip1 labeling indices","volume":"23","author":"Hewedi","year":"2011","journal-title":"J Egypt Natl Canc Inst"},{"key":"R18-14-20210309","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s11102-012-0434-4","article-title":"Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence","volume":"16","author":"Sanchez-Ortiga","year":"2013","journal-title":"Pituitary"},{"key":"R19-14-20210309","doi-asserted-by":"crossref","first-page":"e3598","DOI":"10.1097\/MD.0000000000003598","article-title":"The use of apatinib in treating nonsmall-cell lung cancer: case report and review of literature","volume":"95","author":"Ding","year":"2016","journal-title":"Medicine (Baltimore"},{"key":"R20-14-20210309","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1101\/gad.14.4.391","article-title":"Loss of PTEN facilitates HIF-1-mediated gene expression","volume":"14","author":"Zundel","year":"2000","journal-title":"Genes Dev"},{"key":"R21-14-20210309","first-page":"4575","article-title":"Mutant ras oncogenes upregulate VEGF\/VPF expression: implications for induction and inhibition of tumor angiogenesis","volume":"55","author":"Rak","year":"1995","journal-title":"Cancer Res"},{"key":"R22-14-20210309","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1210\/jcem.85.8.6754","article-title":"Role of matrix metalloproteinase 9 in pituitary tumor behavior","volume":"85","author":"Turner","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R23-14-20210309","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3390\/cancers5020617","article-title":"Osteopontin and MMP9: associations with VEGF expression\/secretion and angiogenesis in PC3 prostate cancer cells","volume":"5","author":"Gupta","year":"2013","journal-title":"Cancers (Basel"},{"key":"R24-14-20210309","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3390\/cancers6010240","article-title":"Gelatinase B\/MMP-9 in tumour pathogenesis and progression","volume":"6","author":"Farina","year":"2014","journal-title":"Cancers (Basel"},{"key":"R25-14-20210309","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5603\/FHC.2012.0002","article-title":"The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer","volume":"50","author":"Groblewska","year":"2012","journal-title":"Folia Histochem Cytobiol"},{"key":"R26-14-20210309","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s11102-015-0648-3","article-title":"MicroRNA involvement in a metastatic non-functioning pituitary carcinoma","volume":"18","author":"Wei","year":"2015","journal-title":"Pituitary"},{"key":"R27-14-20210309","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.3800118","article-title":"Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas","volume":"17","author":"Onguru","year":"2004","journal-title":"Mod Pathol"},{"key":"R28-14-20210309","doi-asserted-by":"crossref","first-page":"11107","DOI":"10.1007\/s13277-014-2401-3","article-title":"EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma","volume":"35","author":"Da Rosa","year":"2014","journal-title":"Tumour Biol"},{"key":"R29-14-20210309","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2008.05.001","article-title":"MicroRNA-10a binds the 5\u2032UTR of ribosomal protein mRNAs and enhances their translation","volume":"30","author":"Orom","year":"2008","journal-title":"Mol Cell"},{"key":"R30-14-20210309","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12020-010-9346-0","article-title":"MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas","volume":"38","author":"Stilling","year":"2010","journal-title":"Endocrine"},{"key":"R31-14-20210309","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12020-008-9129-z","article-title":"RUNX1 and RUNX2 upregulate Galectin-3 expression in human pituitary tumors","volume":"35","author":"Zhang","year":"2009","journal-title":"Endocrine"},{"key":"R32-14-20210309","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1385\/ENDO:29:3:435","article-title":"Patterns of gene expression in pituitary carcinomas and adenomas analyzed by high-density oligonucleotide arrays, reverse transcriptase-quantitative PCR, and protein expression","volume":"29","author":"Ruebel","year":"2006","journal-title":"Endocrine"},{"key":"R33-14-20210309","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrc2657","article-title":"p21 in cancer: intricate networks and multiple activities","volume":"9","author":"Abbas","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"R34-14-20210309","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.anndiagpath.2004.10.002","article-title":"Elevated expression of p21 (WAF1\/Cip1) in hormonally active pituitary adenomas","volume":"9","author":"Neto","year":"2005","journal-title":"Ann Diagn Pathol"},{"key":"R35-14-20210309","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/bjc.1997.521","article-title":"Molecular analysis of p21 and p27 genes in human pituitary adenomas","volume":"76","author":"Ikeda","year":"1997","journal-title":"Br J Cancer"},{"key":"R36-14-20210309","doi-asserted-by":"crossref","first-page":"17498","DOI":"10.1073\/pnas.0804810105","article-title":"p21(Cip1) restrains pituitary tumor growth","volume":"105","author":"Chesnokova","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"R37-14-20210309","doi-asserted-by":"crossref","first-page":"297","DOI":"10.14310\/horm.2002.1358","article-title":"Oncogene-induced senescence in pituitary adenomas and carcinomas","volume":"11","author":"Alexandraki","year":"2012","journal-title":"Hormones"},{"key":"R38-14-20210309","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jor.20036","article-title":"Cyclin D1 and p21 is elevated in the giant cells of giant cell tumors","volume":"24","author":"Kandel","year":"2006","journal-title":"J Orthop Res"},{"key":"R39-14-20210309","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1349-7006.2004.tb03190.x","article-title":"DNA repair and cancer: lessons from mutant mouse models","volume":"95","author":"Ishikawa","year":"2004","journal-title":"Cancer Sci"},{"key":"R40-14-20210309","first-page":"67","article-title":"MGMT immunoexpression in aggressive pituitary adenoma and carcinoma tumors","volume":"21","author":"Lau","year":"2010","journal-title":"Endocr Pathol"},{"key":"R41-14-20210309","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1210\/jc.2014-4350","article-title":"Long-term outcome and MGMT as a predictive marker in 24 patients with atypical pituitary adenomas and pituitary carcinomas given treatment with temozolomide","volume":"100","author":"Bengtsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"R42-14-20210309","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1750-3639.2008.00153.x","article-title":"Anti-O6-methylguanine-methyltransferase (MGMT) immunohistochemistry in glioblastoma multiforme: observer variability and lack of association with patient survival impede its use as clinical biomarker","volume":"18","author":"Preusser","year":"2008","journal-title":"Brain Pathol"},{"key":"R43-14-20210309","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.wneu.2013.09.035","article-title":"Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma","volume":"81","author":"Lee","year":"2014","journal-title":"World Neurosurg"},{"key":"R44-14-20210309","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.833","article-title":"CDKN2A\/p16 inactivation is related to pituitary adenoma type and size","volume":"193","author":"Seemann","year":"2001","journal-title":"J Pathol"},{"key":"R45-14-20210309","first-page":"2493","article-title":"Frequent loss of the P16INK4a gene product in human pituitary tumors","volume":"56","author":"Woloschak","year":"1996","journal-title":"Cancer Res"},{"key":"R46-14-20210309","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/carcin\/22.8.1149","article-title":"Aberrant expression of G(1)\/S regulators is a frequent event in sporadic pituitary adenomas","volume":"22","author":"Simpson","year":"2001","journal-title":"Carcinogenesis"},{"key":"R47-14-20210309","first-page":"162","article-title":"P16 overexpression in pituitary adenomas studied by immunohistochemistry and in situ hybridization","volume":"113","author":"Yi","year":"2000","journal-title":"Chin Med J (Engl"},{"key":"R48-14-20210309","doi-asserted-by":"crossref","first-page":"25863","DOI":"10.1074\/jbc.272.41.25863","article-title":"Differential interaction of the cyclin-dependent kinase (Cdk) inhibitor p27Kip1 with cyclin A-Cdk2 and cyclin D2-Cdk4","volume":"272","author":"Blain","year":"1997","journal-title":"J Biol Chem"},{"key":"R49-14-20210309","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1182\/blood.V88.2.386.bloodjournal882386","article-title":"Molecular thanatopsis: a discourse on the BCL2 family and cell death","volume":"88","author":"Yang","year":"1996","journal-title":"Blood"},{"key":"R50-14-20210309","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0002-9440(10)65323-0","article-title":"Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins","volume":"154","author":"Kulig","year":"1999","journal-title":"Am J Pathol"},{"key":"R51-14-20210309","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0002-9440(10)65649-0","article-title":"Histopathological evaluation of apoptosis in cancer","volume":"153","author":"Soini","year":"1998","journal-title":"Am J Pathol"},{"key":"R52-14-20210309","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3892\/mmr.2015.3459","article-title":"Positive and negative regulators of the metallothionein gene (review)","volume":"12","author":"Takahashi","year":"2015","journal-title":"Mol Med Rep"},{"key":"R53-14-20210309","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mrfmmm.2003.07.013","article-title":"Metallothioneins in human tumors and potential roles in carcinogenesis","volume":"533","author":"Cherian","year":"2003","journal-title":"Mutat Res"},{"key":"R54-14-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5603\/FHC.a2015.0009","article-title":"Metallothioneins in the lung cancer","volume":"53","author":"Werynska","year":"2015","journal-title":"Folia Histochem Cytobiol"},{"key":"R55-14-20210309","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/febs.12731","article-title":"In vivo-folded metal-metallothionein 3 complexes reveal the Cu-thionein rather than Zn-thionein character of this brain-specific mammalian metallothionein","volume":"281","author":"Artells","year":"2014","journal-title":"FEBS J"},{"key":"R56-14-20210309","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000092521","article-title":"Metallothionein isoform 3 gene is differentially expressed in corticotropin-producing pituitary adenomas","volume":"82","author":"Giorgi","year":"2005","journal-title":"Neuroendocrinology"},{"key":"R57-14-20210309","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.3748\/wjg.v20.i16.4723","article-title":"MT1M and MT1G promoter methylation as biomarkers for hepatocellular carcinoma","volume":"20","author":"Ji","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R58-14-20210309","doi-asserted-by":"crossref","first-page":"e874","DOI":"10.1038\/cddis.2013.405","article-title":"Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance","volume":"4","author":"Habel","year":"2013","journal-title":"Cell Death Dis"},{"key":"R59-14-20210309","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11102-014-0597-2","article-title":"Expression pattern of neuronal intermediate filament \u03b1-internexin in anterior pituitary gland and related tumors","volume":"18","author":"Schult","year":"2015","journal-title":"Pituitary"},{"key":"R60-14-20210309","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12022-007-9006-y","article-title":"P53 gene mutations in pituitary carcinomas","volume":"18","author":"Tanizaki","year":"2007","journal-title":"Endocr Pathol"},{"key":"R61-14-20210309","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","article-title":"Pathobiology of pituitary adenomas and carcinomas","volume":"59","author":"Scheithauer","year":"2006","journal-title":"Neurosurgery"},{"key":"R62-14-20210309","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11102-006-9277-1","article-title":"Hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) and guanylate kinase 1 (GUK1) are differentially expressed in GH-secreting adenomas","volume":"9","author":"Da Rocha","year":"2006","journal-title":"Pituitary"},{"key":"R63-14-20210309","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1677\/erc.0.0110333","article-title":"Differential expression of menin in sporadic pituitary adenomas","volume":"11","author":"Theodoropoulou","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"R64-14-20210309","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/EP:15:1:17","article-title":"Analysis of Cox-2 and thromboxane synthase expression in pituitary adenomas and carcinomas","volume":"15","author":"Onguru","year":"2004","journal-title":"Endocr Pathol"},{"key":"R65-14-20210309","first-page":"679","article-title":"Expression of hypoxia-inducible factor-1alpha (HIF-1alpha) in pituitary tumours","volume":"18","author":"Vidal","year":"2003","journal-title":"Histol Histopathol"},{"key":"R66-14-20210309","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1385\/EP:14:1:37","article-title":"Chromogranin A processing in human pituitary adenomas and carcinomas: analysis with region-specific antibodies","volume":"14","author":"Jin","year":"2003","journal-title":"Endocr Pathol"},{"key":"R67-14-20210309","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/01.MP.0000036342.73003.55","article-title":"Topoisomerase IIalpha expression in pituitary adenomas and carcinomas: relationship to tumor behavior","volume":"15","author":"Vidal","year":"2002","journal-title":"Mod Pathol"},{"key":"R68-14-20210309","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1385\/EP:12:2:125","article-title":"Analysis of beta-catenin mutations and alpha-, beta-, and gamma-catenin expression in normal and neoplastic human pituitary tissues","volume":"12","author":"Tziortzioti","year":"2001","journal-title":"Endocr Pathol"},{"key":"R69-14-20210309","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0090-3019(00)00181-6","article-title":"Telomerase activity and the expression of telomerase components in pituitary adenoma with malignant transformation","volume":"53","author":"Harada","year":"2000","journal-title":"Surg Neurol"},{"key":"R70-14-20210309","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0344-0338(99)80032-6","article-title":"An ACTH-producing pituitary carcinoma developing Cushing's disease","volume":"195","author":"Masuda","year":"1999","journal-title":"Pathol Res Pract"},{"key":"R71-14-20210309","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02738884","article-title":"Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas","volume":"10","author":"Lloyd","year":"1999","journal-title":"Endocr Pathol"},{"key":"R72-14-20210309","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1210\/jcem.84.10.6066","article-title":"Low expression of the cell cycle inhibitor p27Kip1 in normal corticotroph cells, corticotroph tumors, and malignant pituitary tumors","volume":"84","author":"Lidhar","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"R73-14-20210309","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02739952","article-title":"Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: a comparative study with pituitary adenomas and normal pituitary tissues","volume":"9","author":"Nose-Alberti","year":"1998","journal-title":"Endocr Pathol"},{"key":"R74-14-20210309","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1227\/00006123-199604000-00027","article-title":"p53 Expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"},{"key":"R75-14-20210309","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/00006123-199601000-00024","article-title":"Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody","volume":"38","author":"Thapar","year":"1996","journal-title":"Neurosurgery"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000005268","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T15:58:43Z","timestamp":1718899123000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201611220-00014"}},"subtitle":["A systematic review"],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":75,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000005268","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727073986.793549914","asserted-by":"object"}]},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}